{"id":"https://openalex.org/W170801347","doi":"https://doi.org/10.1182/blood.v92.10.3569","title":"Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children\u2019s Cancer Group and Pediatric Oncology Branch Study","display_name":"Pharmacokinetics and Pharmacodynamics of Oral Methotrexate and Mercaptopurine in Children With Lower Risk Acute Lymphoblastic Leukemia: A Joint Children\u2019s Cancer Group and Pediatric Oncology Branch Study","publication_year":1998,"publication_date":"1998-11-15","ids":{"openalex":"https://openalex.org/W170801347","doi":"https://doi.org/10.1182/blood.v92.10.3569","mag":"170801347","pmid":"https://pubmed.ncbi.nlm.nih.gov/9808549"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v92.10.3569","doi":"https://doi.org/10.1182/blood.v92.10.3569","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v92.10.3569","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024249524","display_name":"Frank M. Balis","orcid":"https://orcid.org/0000-0002-8117-6926","observed_orcids":["https://orcid.org/0000-0002-8117-6926"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank M. Balis","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109892235","display_name":"John S. Holcenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John S. Holcenberg","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109539569","display_name":"David G. Poplack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Poplack","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jeffrey Ge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Ge","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112213826","display_name":"Harland N. Sather","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harland N. Sather","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061773929","display_name":"Robert F. Murphy","orcid":"https://orcid.org/0000-0003-0358-901X","observed_orcids":["https://orcid.org/0000-0003-0358-901X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert F. Murphy","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew M. Ames","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070461658","display_name":"Mary J. Waskerwitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary J. Waskerwitz","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113683214","display_name":"David G. Tubergen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Tubergen","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042376097","display_name":"Solomon Zimm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Solomon Zimm","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107428870","display_name":"Gerald S. Gilchrist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerald S. Gilchrist","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072781889","display_name":"W. Archie Bleyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Archie Bleyer","raw_affiliation_strings":["From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","the Children's Cancer Group, Arcadia, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD; and the Children\u2019s Cancer Group, Arcadia, CA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"the Children's Cancer Group, Arcadia, CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":6.9103,"has_fulltext":false,"cited_by_count":112,"citation_normalized_percentile":{"value":0.96690547,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"92","issue":"10","first_page":"3569","last_page":"3577"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9350000023841858},{"id":"https://openalex.org/keywords/6-mercaptopurine","display_name":"6-mercaptopurine","score":1.0},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.8100000023841858},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.6499999761581421},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8529999852180481},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9169999957084656},{"id":"https://openalex.org/keywords/thioguanine-nucleotides","display_name":"thioguanine nucleotides","score":0.9589999914169312},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/recurrence-prediction","display_name":"recurrence prediction","score":0.6669999957084656},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5709999799728394},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2777173762","wikidata":"https://www.wikidata.org/wiki/Q418529","display_name":"Mercaptopurine","level":2,"score":0.9347498416900635},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.7936655879020691},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7622821927070618},{"id":"https://openalex.org/C2781107101","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Acute lymphocytic leukemia","level":4,"score":0.7119371294975281},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6941977739334106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5559334754943848},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5364561676979065},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.49163657426834106},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.46798941493034363},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4631376266479492},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.416777640581131},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4158249795436859},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3771427273750305},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.12824541330337524},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001215","descriptor_name":"Asparaginase","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002675","descriptor_name":"Child, Preschool","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006160","descriptor_name":"Guanosine Triphosphate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006160","descriptor_name":"Guanosine Triphosphate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007223","descriptor_name":"Infant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007278","descriptor_name":"Injections, Spinal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015122","descriptor_name":"Mercaptopurine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015122","descriptor_name":"Mercaptopurine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015122","descriptor_name":"Mercaptopurine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016371","descriptor_name":"Cranial Irradiation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018736","descriptor_name":"DNA Adducts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v92.10.3569","doi":"https://doi.org/10.1182/blood.v92.10.3569","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v92.10.3569","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"doi:10.1182/blood.v92.10.3569.422k16_3569_3577","doi":"https://doi.org/10.1182/blood.v92.10.3569.422k16_3569_3577","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v92.10.3569.422k16_3569_3577","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:9808549","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9808549","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W42745244","https://openalex.org/W1507403192","https://openalex.org/W1860659045","https://openalex.org/W1909437603","https://openalex.org/W1937198559","https://openalex.org/W1949967960","https://openalex.org/W1965688215","https://openalex.org/W2000555848","https://openalex.org/W2023073276","https://openalex.org/W2031333115","https://openalex.org/W2037125325","https://openalex.org/W2052866738","https://openalex.org/W2057324853","https://openalex.org/W2057726012","https://openalex.org/W2072032394","https://openalex.org/W2072153264","https://openalex.org/W2081702317","https://openalex.org/W2093793436","https://openalex.org/W2095029217","https://openalex.org/W2097263436","https://openalex.org/W2100423637","https://openalex.org/W2146765441","https://openalex.org/W2173315827","https://openalex.org/W2175441911","https://openalex.org/W2336649003","https://openalex.org/W2502670554","https://openalex.org/W4250634492"],"related_works":["https://openalex.org/W1983922888","https://openalex.org/W2017838616","https://openalex.org/W166171290","https://openalex.org/W1622618735","https://openalex.org/W2105410494","https://openalex.org/W2030648865","https://openalex.org/W2156053216","https://openalex.org/W2010429693","https://openalex.org/W2082017113","https://openalex.org/W2008001256"],"abstract_inverted_index":{"We":[0],"prospectively":[1],"assessed":[2],"the":[3,74,88,110,179,211],"pharmacokinetics":[4],"of":[5,17,65,79,90,104,169,175,206,213],"methotrexate,":[6],"mercaptopurine,":[7],"and":[8,25,42,53,87,102,145,181,192,196],"erythrocyte":[9,197],"thioguanine":[10,132,198],"nucleotide":[11,133,199],"levels":[12,134,200],"in":[13,59,117,178],"a":[14,163,172,188],"homogenous":[15],"population":[16],"children":[18],"with":[19,29,149],"lower":[20],"risk":[21],"acute":[22],"lymphoblastic":[23],"leukemia":[24],"correlated":[26],"pharmacokinetic":[27,208],"parameters":[28,209],"disease":[30],"outcome.":[31],"The":[32,71],"maintenance":[33,214],"therapy":[34,105],"regimen":[35],"included":[36],"daily":[37],"oral":[38,44],"mercaptopurine":[39,55,91,150,160,176,193],"(75":[40],"mg/m2)":[41],"weekly":[43],"methotrexate":[45,51,80],"(20":[46],"mg/m2).":[47],"One":[48],"hundred":[49],"ninety-one":[50],"doses":[52,56],"190":[54],"were":[57,68,135,201],"monitored":[58],"89":[60],"patients.":[61],"Plasma":[62],"drug":[63],"concentrations":[64,195],"both":[66,129],"agents":[67],"highly":[69,137,202],"variable.":[70],"area":[72],"under":[73],"plasma":[75,194],"concentration-time":[76],"curve":[77],"(AUC)":[78],"ranged":[81,92],"from":[82,93],"0.63":[83],"to":[84,95,141,186,223],"12":[85],"micromol*h/L,":[86],"AUC":[89,113,161,177],"0.11":[94],"8":[96],"micromol*h/L.":[97],"Drug":[98],"dose,":[99],"patient":[100,183],"age,":[101],"duration":[103],"did":[106,146],"not":[107,147,216],"account":[108],"for":[109,128],"variability.":[111],"Methotrexate":[112,191],"was":[114,124,162],"significantly":[115],"higher":[116],"girls":[118],"than":[119],"boys":[120],"(P":[121,166],"=.007).":[122],"There":[123],"considerable":[125],"intrapatient":[126],"variability":[127],"agents.":[130],"Erythrocyte":[131],"also":[136],"variable":[138],"(range,":[139],"0":[140],"10":[142],"pmol/g":[143],"Hgb)":[144],"correlate":[148],"dose":[151],"or":[152],"AUC.":[153],"A":[154],"Cox":[155],"regression":[156],"analysis":[157],"showed":[158],"that":[159],"marginally":[164],"significant":[165,189],"=.043)":[167],"predictor":[168],"outcome,":[170],"but":[171,204],"direct":[173],"comparison":[174],"remission":[180],"relapsed":[182],"groups":[184],"failed":[185],"show":[187],"difference.":[190],"variable,":[203],"measurement":[205],"these":[207],"at":[210],"start":[212],"will":[215],"distinguish":[217],"patients":[218],"who":[219],"are":[220],"more":[221],"likely":[222],"relapse.":[224]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}